Vol.19 No.5

Original Article

Comparison of existing disease activity indices in the follow-up of patients with Behçet’s disease

Authors

Farhad Shahram1 , Alireza Khabbazi2 , Abdolhadi Nadji1 , Naghmeh Ziaie1 , Arash Tehrani Banihashemi1 , Fereydoun Davatchi1

  • Beh?et’s Disease Unit, Rheumatology Research Center, Shariati Hospital, Tehran University of Medical Sciences, Kargar Avenue, 14114 Tehran, Iran
  • Rheumatology Ward, Department of Internal Medicine, Tabriz University of Medical Sciences, Tabriz, Iran
Received:

6 March 2009

Accepted:

17 May 2009

Published online:

10 July 2009

Full Text

PDF　(member's only)

Abstract

The objective of this study was to determine the concordance between the Iranian Behçet’s disease dynamic activity measure (IBDDAM) or the Behçet’s disease current activity form (BDCAF) and expert physician global assessment (PGA) in the evaluation of disease activity changes in Behçet’s disease (BD). In a prospective study, 117 consecutive patients with BD were evaluated in their two consecutive follow-up visits by IBDDAM and BDCAF. The change in disease activity was determined (increased, unchanged or decreased) according to the PGA. We used receiver operating characteristic (ROC) curve to determine an appropriate cutoff point for disease activity change. Comparison was made by Stata and kappa analysis. Comparing the area under the ROC curve showed a significant difference between IBDDAM and BDCAF (p < 0.03). The difference was more significant between nonocular IBDDAM and BDCAF (p < 0.002). Better concordance was also observed for IBDDAM (nonocular and total) with PGA than BDCAF. The difference was not significant for ocular IBDDAM. The best cutoff point for nonocular IBDDAM was 0.45, for ocular IBDDAM was 3.5, and for BDCAF was 1 point. IBDDAM was the preferred method for the evaluation of disease activity change in patients with BD (without ocular involvement) considering a change of at least 0.45.

Key words

BDCAF - Behçet’s disease - Disease activity - IBDDAM